Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Diclophenac sodium

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

106 API Suppliers, 21 USDMF, 17 CEP/COS, 13 JDMF, 9 EU WC, 22 KDMF, 30 NDC API, 43 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

41 Drugs in Development

41 Drugs in Development

FINISHED DOSAGE FORMULATIONS

734 FDF Dossiers, 103 FDA Orange Book, 338 Europe, 33 Canada, 62 South Africa, 198 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, SOLUTION;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, DELAYED RELEASE;ORAL - 50MG;0.2MG, TABLET, DELAYED RELEASE;ORAL - 75MG;0.2MG, SOLUTION;TOPICAL - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, GEL;TOPICAL - 1%, SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 7 Evonik, 1 Rochem International Inc, 11 SPI Pharma, 12 Boai NKY Pharmaceuticals Ltd, 5 Gangwal Healthcare, 11 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 6 Kirsch Pharma, 2 Cerata Pharmaceuticals LLP, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 15 Actylis, 3 Aeon Procare, 3 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 2 Ashland, 48 BASF, 1 BioSpectra, 1 CD Formulation, 18 Corel Pharma Chem, 7 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 3 Finar, 12 Gangwal Chemicals, 1 Gloria Interchem, 1 Huzhou Sunflower Pharmaceutical, 13 Ideal Cures, 4 Ingredion Pharma Solutions, 24 Kerry, 3 Keval Exports, 3 Kima Chemical, 6 Lonza Capsugel, 2 Lubrizol Life Science Health, 16 Microlex e.U, 2 Nanjing Bold Chemical, 1 Neelkanth MineChem, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 4 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 24 Roquette, 15 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 11 Sigachi Industries, 4 Silverline Chemicals, 2 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus

EXCIPIENTS BY APPLICATIONS

67 Coating Systems & Additives, 67 Fillers, Diluents & Binders, 51 Solubilizers, 43 Direct Compression, 43 Controlled & Modified Release, 41 Topical, 40 Thickeners and Stabilizers, 40 Granulation, 38 Disintegrants & Superdisintegrants, 27 Parenteral, 23 Lubricants & Glidants, 23 Film Formers & Plasticizers, 19 Taste Masking, 19 Emulsifying Agents, 17 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 10 API Stability Enhancers, 9 Surfactant & Foaming Agents, 5 Empty Capsules, 4 Rheology Modifiers, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 66 News #PharmaBuzz

GLOBAL SALES INFORMATION

40 US Medicaid Prescriptions, 22 Regulatory FDF Prices

MARKET PLACE

72 APIs, 23 FDF Dossiers

PATENTS & EXCLUSIVITIES

26 US Patents, 1 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
31/03/2026	Aarti Drugs	India	AARTI DRUGS LIMITED.	224MF10159	Diclofenac Sodium JP	2012-08-16	2015-02-04	Mahendra Industrial Estate, Ground floor, Plot no: 109-D, Road no: 29, Sion (E), Mumbai-400 022 India
31/03/2026	Amoli Organics	India	Amoli Organics (A Division of Umedica Laboratories Pvt Ltd.)	218MF10010	Japanese Pharmacopoeia Diclofenac Sodium (for manufactu...	2006-01-27	2022-12-15	407, Dalamal House, Jamnalal Bajaj Road, Nariman Point, Mumbai-400021. India

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Diclophenac Sodium

Diclophenac sodium

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

106 API Suppliers

21 USDMF

17 CEP/COS

13 JDMF

9 EU WC

22 KDMF

30 NDC API

43 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

41 Drugs in Development

FINISHED DOSAGE FORMULATIONS

734 FDF Dossiers

103 FDA Orange Book

338 Europe

33 Canada

62 South Africa

198 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;TOPICAL - 2% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, DELAYED RELEASE;ORAL - 50MG;0.2MG

TABLET, DELAYED RELEASE;ORAL - 75MG;0.2MG

SOLUTION;TOPICAL - 1.5% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 3% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

GEL;TOPICAL - 1%

SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

7 Evonik

1 Rochem International Inc

11 SPI Pharma

12 Boai NKY Pharmaceuticals Ltd

5 Gangwal Healthcare

11 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 Capital Farma

6 Kirsch Pharma

2 Cerata Pharmaceuticals LLP

1 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

15 Actylis

3 Aeon Procare

3 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

2 Ashland

48 BASF

1 BioSpectra

1 CD Formulation

18 Corel Pharma Chem

7 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

3 Finar

12 Gangwal Chemicals

1 Gloria Interchem

1 Huzhou Sunflower Pharmaceutical

13 Ideal Cures

4 Ingredion Pharma Solutions

24 Kerry

3 Keval Exports

3 Kima Chemical

6 Lonza Capsugel

2 Lubrizol Life Science Health

16 Microlex e.U

2 Nanjing Bold Chemical

1 Neelkanth MineChem

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

4 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

TABLET, EXTENDED RELEASE;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;TOPICAL - 2% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;TOPICAL - 1.5% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

GEL;TOPICAL - 3% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;INTRAVENOUS - 37.5MG/ML (37.5MG/ML) Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons